Page last updated: 2024-09-04

ezetimibe and Heart Disease, Ischemic

ezetimibe has been researched along with Heart Disease, Ischemic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Li, S; Schooling, CM1
Angiolillo, DJ; Cao, D; Claessen, BE; Gibson, CM; Guedeney, P; Lepor, N; Mehran, R1
Kuang, H; Li, L; Lu, T; Shou, W; Yi, Q; Zhou, X1
Bang, LE; Gislason, GH; Høfsten, DE; Jensen, JS; Køber, LV; Pallisgaard, J; Ripa, MS; Schjerning, AM; Theilade, JE; Weeke, PE1
Acharjee, S; Boden, WE; Chaitman, BR; Dada, M; Hartigan, PM; Kostuk, W; Mancini, GB; Maron, DJ; Sedlis, SP; Spertus, JA; Teo, KK; Weintraub, WS1
Díaz Gómez, JM1
SoRelle, R1
Abesadze, IT; Gordeev, ML; Korzhenevskaia, KV; Kozulin, VIu; Nil'k, RIa; Panov, AV; Shliakhto, EV1

Reviews

2 review(s) available for ezetimibe and Heart Disease, Ischemic

ArticleYear
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review.
    Journal of the American Heart Association, 2020, 12-15, Volume: 9, Issue:24

    Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, LDL; Cost-Benefit Analysis; Dicarboxylic Acids; Eicosapentaenoic Acid; Ezetimibe; Fatty Acids; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Male; Middle Aged; Myocardial Ischemia; PCSK9 Inhibitors; Practice Guidelines as Topic; Risk Reduction Behavior; RNA, Small Interfering; Secondary Prevention

2020
[Cardiovascular mortality in kidney transplatation].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2008, Volume: 28 Suppl 5

    Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Comorbidity; Coronary Angiography; Diabetes Mellitus; Dyslipidemias; Ezetimibe; Humans; Kidney Diseases; Kidney Transplantation; Myocardial Ischemia; Obesity; Postoperative Complications; Preoperative Care; Prognosis; Risk Factors

2008

Other Studies

6 other study(ies) available for ezetimibe and Heart Disease, Ischemic

ArticleYear
Investigating the effects of statins on ischemic heart disease allowing for effects on body mass index: a Mendelian randomization study.
    Scientific reports, 2022, 03-03, Volume: 12, Issue:1

    Topics: Anticholesteremic Agents; Body Mass Index; Cholesterol, LDL; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mendelian Randomization Analysis; Myocardial Ischemia; Proprotein Convertase 9

2022
Early severe coronary heart disease and ischemic heart failure in homozygous familial hypercholesterolemia: A case report.
    Medicine, 2018, Volume: 97, Issue:42

    Topics: Adolescent; Anticholesteremic Agents; Aspirin; Coronary Disease; Ezetimibe; Female; Heart Failure; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Mutation; Myocardial Ischemia; Platelet Aggregation Inhibitors; Receptors, LDL; Xanthogranuloma, Juvenile

2018
Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study.
    BMJ open, 2019, 04-01, Volume: 9, Issue:4

    Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Denmark; Diabetes Mellitus; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Ischemia; PCSK9 Inhibitors; Practice Patterns, Physicians'; Stroke

2019
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluat
    Journal of the American College of Cardiology, 2013, Nov-12, Volume: 62, Issue:20

    Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Clinical Trials as Topic; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Life Style; Male; Middle Aged; Myocardial Ischemia; North America; Randomized Controlled Trials as Topic; Secondary Prevention

2013
Stenosis and the drug-eluting stent.
    Circulation, 2004, Mar-23, Volume: 109, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Azetidines; Cardiology; Coronary Restenosis; Diabetes Complications; Ezetimibe; Humans; Hypercholesterolemia; Myocardial Infarction; Myocardial Ischemia; Perindopril; Radionuclide Imaging; Randomized Controlled Trials as Topic; Stents

2004
[Functional state of endothelium and oxidant activity of leucocytes in patients with ischemic heart disease after coronary bypass surgery].
    Kardiologiia, 2007, Volume: 47, Issue:4

    Topics: Adult; Anticholesteremic Agents; Azetidines; Case-Control Studies; Coronary Angiography; Coronary Artery Bypass; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Humans; Leukocytes; Luminescent Measurements; Male; Microscopy; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Severity of Illness Index; Simvastatin; Treatment Outcome

2007